Price $127.43 |
Market Cap
3.82B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
74.8
|
P/B
5.06
|
P/S
3.85
|
Dividend %
0.60%
|
|
P/CF
334.8
|
P/FCF
52.1
|
Op. Cash Flow
111.9K
|
FCF
2.4
|
|
Op. Margin
10.20%
|
Net Margin
5.50%
|
ROE
7.60%
|
ROI
3.70%
|
|
ROA
3.10%
|
EPS Growth
-
|
Current Ratio
2.2
|
Debt/Equity
103.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.59 | - | - | 30.3M | Strong Buy |
| Inogen Inc (INGN) | $46.75 | - | - | 1.36B | Strong Buy |
| Assertio Holdings Inc (ASRT) | $0.90 | - | - | 48.5M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.71 | - | - | 709M | Strong Buy |
| Endo International PLC (ENDP) | $2.76 | - | - | 499.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
